Related Experiment Video

Updated: Jan 19, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.7K

High-Dose Testosterone and Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer

Bryce Raymon Christensen1, Pedro C Barata2, Elisa M Ledet1

  • 1Tulane University School of Medicine, New Orleans, LA; Tulane Cancer Center, New Orleans, LA.

Clinical Genitourinary Cancer
|September 21, 2019
PubMed
Abstract

No abstract available in PubMed .

Keywords:
AR amplificationAndrogenPSARadiopharmaceuticalctDNA

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

681
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.6K

Related Concept Videos